INSIDER TRADING

Cluster buy at Orchestra BioMed Holdings, Inc.: four insiders add $230,000 of OBIO

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Cluster buy at Orchestra BioMed Holdings, Inc.: four insiders add $230,000 of OBIO

Four insiders reported purchases totalling $230,000 in Form 4 filings. Information only, not investment advice.

Form 4 filings show four Orchestra BioMed Holdings, Inc. insiders buying stock on Nov 9, for a total of $230,000.

David Pacitti (director) made the largest purchase, $100,000 at an average of $5.00 a share. Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan.

Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy. Eric S Fain (director) is the latest to report, in a filing on Nov 9.

Details from the SEC filing:

Who bought when
InsiderRoleTrade dateSharesAvg. priceValueFiling
Andrew Lawrence TaylorCFONov 91,000$5.00$5,000App · SEC
David P HochmanOfficerNov 95,000$5.00$25,000App · SEC
David PacittiDirectorNov 920,000$5.00$100,000App · SEC
Eric S FainDirectorNov 920,000$5.00$100,000App · SEC
Total$230,000

See the full OBIO insider activity report

Each row of the table links to its Form 4 on SEC.gov.

Browse the latest insider buying · Read the daily insider trading roundup

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.